Artemis Hospitals
In India, immunotherapy with Keytruda typically costs from AUD $5,046 to AUD $8,939 per session. The final price depends on the required dosage per vial, hospital tier, and city. In Australia, patients often face costs of AUD $11,390 for similar treatments when not covered by the PBS. By choosing India, Australians can save approximately 38% while receiving care at JCI-accredited facilities.
Bookimed Expert Insight: Australian patients can find exceptional value at high-volume centres like HCG Manavata Cancer Centre. This facility has treated over 100,000 global patients and features specialists like Dr. Raj Nagarkar. Choosing larger networks such as Apollo Hospital Indraprastha or Manipal Hospitals ensures access to advanced diagnostics. These hubs often offer the latest immunotherapy protocols at a fraction of Australian private healthcare rates.
| India | Thailand | Turkey | |
| Immunotherapy with Keytruda (Pembolizumab) | from AUD $5,046 | from AUD $11,534 | from AUD $4,758 |
No hidden fees – just official clinic prices. Pay at the clinic for Immunotherapy with Keytruda (Pembolizumab) upon arrival and use a flexible instalment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Immunotherapy with Keytruda (Pembolizumab) and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Immunotherapy with Keytruda (Pembolizumab) journey.
Dr. Ahmer Arif Shaikh is a surgical oncologist at HCG Manavata Cancer Centre. He specializes in oral cancer treatment with a focus on organ preservation. Dr. Shaikh completed fellowship training in head and neck surgical oncology at the same center. He is proficient in performing major maxillofacial and head and neck surgeries.
The doctor is an experienced nuclear medicine specialist at HCG Manavata Cancer Centre with 12 years in the field. The doctor specializes in various nuclear scans, PET-CT scans, and nuclear cardiology services, demonstrating proficiency in radioiodine and Lu-177 RN therapies. Over the course of their career, the doctor has managed more than 30,000 PET scans and treated over 1,000 thyroid cancer patients. Additionally, the doctor has contributed to the field through published papers in various medical journals.
Professor Raj Nagarkar has performed over 50,000 cancer surgeries and leads clinical research as the Managing Director of HCG Manavata Cancer Centre.
Dr. Girish Badarkhe is a hematology-oncologist at HCG Manavata Cancer Centre in Nashik. He specializes in leukemia, multiple myeloma, and bone marrow transplants. Dr. Badarkhe treats both adults and children with complex blood disorders. He holds a DM in Clinical Hematology from Medical College, Calcutta.